Patient Square Capital LP Liquidia Corp Transaction History
Patient Square Capital LP
- $269 Billion
- Q3 2024
A detailed history of Patient Square Capital LP transactions in Liquidia Corp stock. As of the latest transaction made, Patient Square Capital LP holds 7,182,532 shares of LQDA stock, worth $76.5 Million. This represents 26.66% of its overall portfolio holdings.
Number of Shares
7,182,532
Previous 7,182,532
-0.0%
Holding current value
$76.5 Million
Previous $86.2 Billion
16.67%
% of portfolio
26.66%
Previous 40.01%
Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
171Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Black Rock Inc. New York, NY4.24MShares$45.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$36.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$35 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$34 Million16.08% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$24.1 Million1.86% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $685M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...